MELI vs ORMP
MercadoLibre Inc. (MELI) versus Oramed Pharmaceuticals Inc (ORMP) — a side-by-side from cached financials, not a winner call.
MercadoLibre Inc. (MELI) is a internet retail company listed on NASDAQ.
Oramed Pharmaceuticals Inc (ORMP) is a biotechnology company listed on US.
Latest reported MELI revenue for 2024-12-31 was $20.78B. Net income was $1.91B. Revenue was up 387.6% from 2023-12-31 to 2024-12-31. MELI currently screens at market cap $82.73B and trailing P/E 43.1.
Latest reported ORMP revenue for 2023-12-31 was $1.3M. Net income was $5.5M. Revenue was up 48.2% from 2022-12-31 to 2023-12-31. ORMP currently screens at market cap $87.2M.
MELI currently screens at market cap $82.73B and trailing P/E 43.1. ORMP currently screens at market cap $87.2M.
Not investment advice. Open the MELI and ORMP stock pages for the full models.
Not investment advice.